Agamah, F
Iepsen EW, Lundgren J, Dirksen C, et al
In clinical trials , people with obesity who used higher doses of Mounjaro, alongside diet and lifestyle changes, achieved significant weight loss over time
For BPC-157 in particular, the recovery reputation rests heavily on preclinical work, so a careful provider frames it as supportive and investigational rather than proven
So I proposed this post hoc analysis to look at more of the totality of effects of these two drugs using a six-component composite end point. The six components were all-cause mortality, MI, stroke, coronary revascularization, hospitalization for heart failure and a composite of adverse renal outcomes
Due to heightened clinician and patient interest, the trials enrollment size was increased to 176 from the original target